Microfluidics for positron emission tomography probe development

Molecular Imaging

Volumn 9, Issue 4, 2010, Pages 175-191

  Wang, Ming Wei ^a,b,c   Lin, Wei Yu ^a,b,c   Liu, Kan ^a,b,c   Masterman Smith, Michael ^a,b,c   Shen, Clifton Kwang Fu ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CALIFORNIA NANOSYSTEMS INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOTRON FACILITY; DECENTRALIZED MODELS; DEVICE ARCHITECTURES; HIGH DEMAND; MICRO-FLUIDIC REACTORS; MICROFLUIDIC PLATFORMS; MOLECULAR IMAGING; PET PROBE; PROOF OF PRINCIPLES; PURIFICATION PROCESS; SPECIFIC ACTIVITY; STAND -ALONE;

MICROFLUIDICS; POSITRONS; PROBES; REACTION RATES;

POSITRON EMISSION TOMOGRAPHY;

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOISOTOPE;

ANIMAL; CHEMISTRY; HUMAN; INSTRUMENTATION; METHODOLOGY; MICROFLUIDIC ANALYSIS; POSITRON EMISSION TOMOGRAPHY; REVIEW;

ANIMALS; FLUORODEOXYGLUCOSE F18; HUMANS; MICROFLUIDIC ANALYTICAL TECHNIQUES; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES;

EID: 77956483680     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2010.00027     Document Type: Review

References (90)

1. Phelps ME. editor. PET: molecular imaging and its biological applications. New York: Springer; 2004.
2. Phelps ME. Positron emission tomography provides molecular imaging of biological processes. Proc Natl Acad Sci U S A 2000;97: 9226-33.
3. Welch MJ, Laforest R, Lewis JS. Production of non-standard PET radionuclides and the application of radiopharmaceuticals labeled with these nuclides. In: Schubiger A, Lehmann L, Friebe M, editors. PET chemistry: the driving force in molecular imaging. Vol 62 Berlin: Springer; 20p. 159-81.
4. Maecke HR, Andre JP. 68Ga-PET radiopharmacy: a generator- based alternative to 18F-radiopharmacy. In: Schubiger A, Lehmann L, Friebe M, editors. PET chemistry: the driving force in molecular imaging. Vol 62.Berlin: Springer; 20p. 215-42.
5. Dehdashti F, Flanagan FL, Mortimer JE, et al. Positron emission tomographic assessment of''metabolic FLARE'' to predict response of metastatic breast cancer to antiestrogen therapy. Eur J Nucl Med 1999;26:51-6.
6. Ishiwata K, Ogi N, Shimada J, et al. Search for PET probes for imaging the globus pallidus studied with rat brain ex vivo autoradiography. Ann Nucl Med 2000;14:461-6.
7. Okarvi SM. Recent progress in fluorine-18 labelled peptide radiopharmaceuticals. Eur J Nucl Med 2001;28:929-38.
8. Czernin J, Phelps ME. Positron emission tomography scanning: current and future applications. Annu Rev Med 2002;53:89-112.
9. Cook GJ, Wegner EA, Fogelman I. Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging. Semin Nucl Med 2004;34:122-33.
10. Gambhir SS, Czernin J, Schwimmer J, et al. A tabulated summary of the FDG PET literature. J Nucl Med 2001;42:1S-93S.
11. Even-Sapir E, Mishani E, Flusser G, et al. 18F-Fluoride positron emission tomography and positron emission tomography/computed tomography. Semin Nucl Med 2007;37:462-9.
12. Vallabhajosula S. F-18-Labeled positron emission tomographic radio-pharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization. Semin Nucl Med 2007;37: 400-19.
13. Shields AF, Grierson JR, Dohmen BM, et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med 1998;4:1334-6.
14. Salskov A, Tammisetti VS, Grierson J, et al. FLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3′-deoxy- 3′-[18F]fluorothymidine. Semin Nucl Med 2007;37:429- 39.
15. Wester HJ, Herz M, Weber W, et al. Synthesis and radio- pharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med 1999;40:205-12.
16. Pöpperl G, Götz C, Rachinger W, et al. Value of O-(2- [18F]fluoroethyl)-L-tyrosine PET for the diagnosis of recurrent glioma. Eur J Nucl Med Mol Imaging 2004;31:1464-70.
17. Weckesser M, Langen KJ, Rickert C H, et al. O-(2-[18F]fluorethyl)- L-tyrosine PET in the clinical evaluation ofprimarybrain tumours. Eur J Nucl Med Mol Imaging 2005;32:422-9.
18. Langen KJ, Hamacher K, Weckesser M, et al. O-(2-[18F]fluoroethyl)- L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 2006;33:287-94.
19. Seibyl JP, Chen W, Silverman DH. 3,4-Dihydroxy-6-[18F]-fluoro- L-phenylALAnine positron emission tomography in patients with central motor disorders and in evaluation of brain and other tumors. Semin Nucl Med 2007;37:440-50.
20. Cropley VL, Innis RB, Nathan PJ, et al. Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans. Synapse 2008;62:399-408.
21. Lu S, Giamis AM, Pike VW. Synthesis of [18F]fallypride in a micro- reactor: rapid optimization and multiple-production in small doses for micro-PET studies. Curr Radiopharm 2009;2:49-55.
22. Thorwarth D, Eschmann SM, Paulsen F, et al. A model of reoxygenation dynamics of head-and-neck tumors based on serial 18F-fluoromisonidazole positron emission tomography investigations. Int J Radiat Oncol 2007;68:515-21.
23. Lee ST, Scott AM. Hypoxia positron emission tomography imaging with 18F-fluoromisonidazole. Semin Nucl Med 2007;37: 451-61.
24. Thorwarth D, Eschmann SM, Holzner F, et al. Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients. Radiother Oncol 2006; 80:151-6.
25. Padhani AR, Krohn KA, Lewis JS, et al. Imaging oxygenation of human tumours. Eur Radiol 2007;17:861-72.
26. Krasikova R. Synthesis modules and automation in F-18 labeling. In: Schubiger A, Lehmann L, Friebe M, editors. PET chemistry: the driving force in molecular imaging. Vol 62Berlin: Springer; 2007. p. 289-316.
27. Mitchell MC, Spikmans V, de Mello AJ. Microchip-based synthesis and analysis: control of multicomponent reaction products and intermediates. Analyst 2001;126:24-7.
28. Liu J, Enzelberger M, Quake S. A nanoliter rotary device for polymerase chain reaction. Electrophoresis 2002;23:1531-6.
29. Toriello NM, Douglas ES, Thaitrong N, et al. Integrated microfluidic bioprocessor for single-cell gene expression analysis. Proc Natl Acad Sci U S A 2008;105:20173-8.
30. Whitesides GM. The origins and the future of microfluidics. Nature 2006;442:368-73.
31. Miller PW. Radiolabelling with short-lived PET (positron emission tomography) isotopes using microfluidic reactors. J Chem Technol Biotechnol 2009;84:309-15.
32. Elizarov AM. Microreactors for radiopharmaceutical synthesis. LabChip 2009;9:1326-33.
33. Audrain H. Positron emission tomography (PET) and microfluidic devices: a breakthrough on the microscale? Angew Chem Int Ed (Engl) 2007;46:1772-5.
34. Lu SY, Pike VW. Micro-reactors for PET tracer labeling. In: Schubiger A, Lehmann L, Friebe M, editors. PET chemistry: the driving force in molecular imaging. Vol 62. Berlin: Springer; 20p. 271-87.
35. Cai LS, Lu SY, Pike VW. Chemistry with F-18 fluoride ion. Eur J Org Chem 2008;17:2853-73.
36. Jahnisch K, Hessel V, Lowe H, et al. Chemistry in microstructured reactors. Angew Chem Int Ed (Engl) 2004;43:406-46.
37. Watts P, Wiles C. Micro reactors: a new tool for the synthetic chemist. Org Biomol Chem 2007;5:727-32.
38. Watts P, Wiles C. Recent advances in synthetic micro reaction technology. Chem Commun 2007;5:443-67.
39. Kobayashi J, Mori Y, Kobayashi S. Multiphase organic synthesis in microchannel reactors. Chem Asian J 2006;1:22-35.
40. Lin W-Y, Wang Y, Wang S, et al. Integrated microfluidic reactors. Nanotoday 2009;4:470-81.
41. Lee CC, Sui Gd, Elizarov A, et al. Multistep synthesis of a radiolabeled imaging probe using integrated microfluidics. Science 2005;310:1793-96.
42. Wang JY, Sui Gd, Mocharla VP, et al. Integrated microfluidics for parallel screening ofan in situ clickchemistrylibrary. Angew Chem Int Ed (Engl) 2006;45:5276-81.
43. Wang Y, Lin W-Y, Liu K, et al. An integrated microfluidic device for large-scale in situ click chemistry screening. Lab Chip 2009;9: 2281-85.
44. Huang YY, CAStrataro P, Lee CC, et al. Solvent resistant microfluidic DNA synthesizer. Lab Chip 2007;7:24-6.
45. Thorsen T, Maerkl SJ, Quake SR. Microfluidic large-scale integration. Science 2002;298:580-4.
46. Squires TM, Quake SR. Microfluidics: fluid physics at the nanoliter scale. Rev Mod Phys 2005;77:977-1026.
47. Duffy DC, McDonald JC, Schueller OJA, et al. Rapid prototyping of microfluidic systems in poly(dimethylsiloxane). Anal Chem 1998;70:4974-84.
48. BALAgadde FK, You LC, Hansen CL, et al. Long-term monitoring of bacteria undergoing programmed population control in a micro- chemostat. Science 2005;309:137-40.
49. Unger MA, Chou HP, Thorsen T, et al. Monolithic microfabri- cated valves and pumps by multilayer soft lithography. Science 2000;288:113-6.
50. Chou HP, Unger MA, Quake SR. A microfabricated rotary pump. Biomed Microdevices 2001;3:323-30.
51. Lee JN, Park C, Whitesides GM. Solvent compatibility of poly(dimethylsiloxane)-based microfluidic devices. Anal Chem 2003;75:6544-54.
52. Mukhopadhyay R. When PDMS isn't the best. Anal Chem 2007;79: 3248-53.
53. Zhang J, Li Y, Liu J, et al. The analysis of radiolysis impurities in 18F-FDG and methods of repurification. J Radioanal Nucl Chem 2010 DOI: 10.1007/s10967-009-0408-9.
54. Jacobson MS, Dankwart HR, Mahoney DW. Radiolysis of 2-[F-18]fluoro-2- deoxy-D-glucose ([F-18]FDG) and the role of ethanol and radioactive concentration. Appl Radiat Isot 2009;67:990-5.
55. Wuest F, Berndt M, Kniess T. Carbon-11 labeling chemistry based upon [11C]methyl iodide. In: Schubiger A, Lehmann L, Friebe M, editors. PET chemistry: the driving force in molecular imaging. Vol 62. Berlin: Springer; 20p. 183-213.
56. Miller PW, Long NJ, Vilar R, et al. Synthesis of C-11, F-18, O-15, and N-13 radiolabels for positron emission tomography. Angew Chem Int Ed (Engl) 2008;47:8998-9033.
57. Kracht LW, Miletic H, Busch S, et al. Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology. Clin Cancer Res 2004;10:7163-70.
58. Nariai T, Tanaka Y, Wakimoto H, et al. Usefulness of L- [methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma. J Neurosurg 2005;103:498-507.
59. Reske SN, Blumstein NM, Neumaier B, et al. Imaging prostate cancer with 11C-choline PET/CT. J Nucl Med 2006;47:1249-54.
60. Picchio M, Messa C, Landoni C, et al. Value of [11C]choline- positron emission tomography for restaging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography. J Urol 2003;169:1337-40.
61. Oyama N, Miller TR, Dehdashti F, et al. 11C-Acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. J Nucl Med 2003;44:549-55.
62. Ho CL, Yu SC, Yeung DW. 11C-Acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med 2003;44:213-21.
63. Frank GK, Bailer UF, Henry SE, et al. Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11C]raclopride. Biol Psychiatry 2005; 58:908-12.
64. Ohnishi T, Hayashi T, Okabe S, et al. Endogenous dopamine release induced by repetitive transcranial magnetic stimulation over the primary motor cortex: an [11C]raclopride positron emission tomography study in anesthetized macaque monkeys. Biol Psychiatry 2004;55:484-9.
65. Laruelle M. Imaging synaptic neurotransmission with in vivo binding comPETition techniques: a critical review. J Cereb Blood Flow Metab 2000;20:423-51.
66. Bohnen NI, Kuwabara H, Constantine GM, et al. Grooved pegboard test as a biomarker of nigrostriatal denervation in Parkinson's disease. Neurosci Lett 2007;424:185-9.
67. Zheng QH, Mock BH. Purification of carbon-11 PET radiotracers from unlabeled precursors by preparative HPLC and SPE. Biomed Chromatogr 2005;19:671-6.
68. Brashear A, Mulholland GK, Zheng QH, et al. PET imaging of the pre-synaptic dopamine uptake sites in rapid-onset dystonia- parkinsonism (RDP). Mov Disord 1999;14:132-7.
69. Lu SY, Watts P, Chin FT, et al. Syntheses of C-11- and F-18-labeled carboxylic esters within a hydrodynamically-driven micro-reactor. Lab Chip 2004;4:523-5.
70. Brady F, Luthra SK, Gillies JM, et al. Use ofmicrofabricated devices for radiosynthesis of radiotracers for positron emission tomography. US Patent Application, 2005/0226776 A1.
71. Langstom B, Itsenko O, Rahman O. [11C]Carbon monoxide, a versatile and useful precursor in labelling chemistry for PET ligand development. J Label Compd Radiopharm 2007;50:794-810.
72. Miller PW, Long NJ, de Mello AJ, et al. Rapid formation ofamides via carbonylative coupling reactions using a microfluidic device. Chem Commun 2006;5:546-8.
73. Miller PW, Long NJ, de Mello AJ, et al. Rapid multiphase carbonylation reactions by using a microtube reactor: applications in positron emission tomography C-11-radiolabeling. Angew Chem Int Ed (Engl) 2007;46:2875-8.
74. Warburg O, Posener K, Negelein EV. The metabolism of cancer cells. Biochem Z 1924;152:129-69.
75. Hamacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic-substitution. J Nucl Med 1986;27:235-8.
76. Hamacher K, Blessing G, Nebeling B. Computer-aided synthesis (CAS) of no-carrier-added 2-[18F]fluoro-2-deoxy-D-glucose-an efficient automated-system for the aminopolyether-supported nucleophilic fluorination. Appl Radiat Isot 1990;41:49-55.
77. Padgett HC, Schmidt DG, Luxen A, et al. Computer-controlled radiochemical synthesis-a chemistry process-control unit for the automated production of radiochemicals. Appl Radiat Isot 1989; 40:433-45.
78. Gillies JM, Prenant C, Chimon GN, et al. Microfluidic technology for PET radiochemistry. Appl Radiat Isot 2006;64:333-6.
79. Gillies JM, Prenant C, Chimon GN, et al. Microfluidic reactor for the radiosynthesis of PET radiotracers. Appl Radiat Isot 2006;64: 325-32.
80. Steel CJ, O'Brien AT, Luthra SK, et al. Automated PET radio- syntheses using microfluidic devices. J Label Compd Radiopharm 2007;50:308-11.
81. Wester HJ, Schoultz BW, Hultsch C, et al. Fast and repetitive in- capillaryproductionofF-18FDG.Eur J Nucl Med MolImaging 2009;36:653-8.
82. Hong JW, Studer V, Hang G, et al. A nanoliter-scale nucleic acid processor with parallel architecture. Nat Biotechnol 2004;22:435-9.
83. Elizarov AM, Kolb H, Heath J, et al. Microfluidic chip capable of synthesizing radioactively labeled molecules on a scale suitable for human imaging with positron emission tomography. WIPO patent application wo/2007/041486.
84. Briard E, Zoghbi SS, Simeon FG, et al. Single-step high-yield radiosynthesis and evaluation of a sensitive 18F-labeled ligand for imaging brain peripheral benzodiazepine receptors with PET. J Med Chem 2009;52:688-99.
85. Telu S, Chun J, Simeon FG, et al. Synthesis of an mGluR5 radio- ligand, [F-18]SP203B, through radiofluorination of a diaryliodo- nium salt precursor. J Label Compd Radiopharm 2009;52 Suppl 1:S4.
86. Patel S, Ndubizu O, Hamill T, et al. Screening Cascade and development of potential positron emission tomography radio- tracers for mGluR5: in vitro and in vivo characterization. Mol Imaging Biol 2005;7:314-23.
87. Hessel V, Lowe H, Schonfeld F. Micromixers-a review on passive and active mixing principles. Chem Eng Sci 2005;60:2479-501.
88. Zheng B, Tice JD, Roach LS, et al. A droplet-based, composite PDMS/glass capillary microfluidic system for evaluating protein crystallization conditions by microbatch and vapor-diffusion methods with on-chip X-ray diffraction. Angew Chem Int Ed (Engl) 2004;43:2508-11.
89. Song H, Chen DL, Ismagilov RF. Reactions in droplets in microflulidic channels. Angew Chem Int Ed (Engl) 2006;45:7336-56.
90. Olma S, Liu K, Chen Y, et al. Microfluidic droplet mixer for fluorine-18 labeling of biomolecules. J Label Compd Radiopharm 2009;52 Suppl 1:S10.